MedTrace Logo

Smoking Habits and Smoking Cessation in Young Adults

NCT01531049 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-06-05

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy and effectiveness of varenicline and nicotine patch combined with motivational interview technique in smoking cessation of young adults over 12 months follow-up.

Conditions

  • Smoking Cessation
  • Smoking
  • Habits

Interventions

DRUG

varenicline

days 1.-3 0,5mgx1/day, days 4.-7 0,5mgx2/day, day 8 to the 12weeks 1mgx2 /day

DRUG

Nicotine cutaneous patch 15mg/16h

One patch for 16hours/day and duration of 8 weeks.

DRUG

Nicotine cutaneous patch 10mg/16h

One patch 16hours/day and duration of 8 weeks

OTHER

Placebo cutaneous patch

No active medication.O ne patch 16hours and duration for 8 weeks

Sponsors & Collaborators

  • University of Oulu

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • Tuula Toljamo

    lead OTHER

Principal Investigators

  • Pentti Nieminen, PhD · Medical Informatics and Statistics Research Group, University of Oulu

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2015-12-31
Completion
2016-09-02

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01531049 on ClinicalTrials.gov